Briefing: A Huntington’s researcher on the UniQure-FDA fray
Strategic angle: A Huntington's researcher treads lightly into the UniQure-FDA fray, J&J wins approval for a first-of-its kind psoriasis pill, and more in today's Readout newsletter.
Browse the full archive, newest first.
Strategic angle: A Huntington's researcher treads lightly into the UniQure-FDA fray, J&J wins approval for a first-of-its kind psoriasis pill, and more in today's Readout newsletter.
Strategic angle: More paid parking spots could raise revenue, but it could upset millions of locals
Strategic angle: The Commodity Futures Trading Commission faces challenges in policing insider trading in the evolving market of prediction platforms.
Strategic angle: A transmission ground wire might not have been properly connected during manufacturing.
Strategic angle: You turned in a wealth of answers, a deeply unsurprising number of which came from Toyota.
Strategic angle: The Trump administration aims to strengthen supply chains amid ongoing geopolitical tensions.
Strategic angle: As the Iran crisis widens, BRICS faces mounting pressure to respond — but internal rifts and competing interests are limiting the bloc's ability to act as a geopolitical actor.
Strategic angle: TD Cowen expresses optimism for Rivian Automotive as it prepares for the R2 launch.
Strategic angle: Crowds flee as gunfire erupts during traditional fire festival.